Sanofi, GSK get approval for Phase 3 COVID-19 vaccine trial in India EP News Bureau Jul 8, 2021 In a two-stage approach, the study will initially investigate the efficacy of a vaccine formulation targeting the original virus…
COVAXIN is well tolerated with no serious adverse events in Phase I trials Press Trust of India Dec 17, 2020 The trial was conducted on volunteers from diverse geographic locations and socioeconomic conditions, enrolling 375 participants…
Sorrento gets US FDA nod for Phase 1 clinical trial of neutralising antibody in COVID-19 patients EP News Bureau Sep 17, 2020 Sorrento had earlier informed that COVI-GUARD (STI-1499) demonstrated 100 per cent in vitro neutralizing effect against SARS-CoV-2…
